Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes

doi:10.1084/jem.175.3.863

This Article

	Full Text (PDF, 745K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Hiruma, K.
	Articles by Gress, R. E.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Hiruma, K.
	Articles by Gress, R. E.


Social Bookmarking

	What's this?

ARTICLES

Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes

K Hiruma, H Nakamura, PA Henkart and RE Gress
Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland 20892.

Veto cell-mediated suppression of cytotoxic T lymphocyte (CTL) responses has been proposed as one mechanism by which self-tolerance is maintained in mature T cell populations. We have previously reported that murine bone marrow cells cultured in the presence of high-dose interleukin 2 (IL-2) (activated bone marrow cells [ABM]) mediate strong veto suppressor function. To examine mechanisms by which ABM may suppress precursor CTL (p-CTL) responses, we used p-CTL generated from spleen cells of transgenic mice expressing a T cell receptor specific for H-2 Ld. It was demonstrated that the cytotoxic response by these p- CTL after stimulation with irradiated H-2d/k spleen cells was suppressed by DBA/2 (H-2d) ABM, but not by B10.BR (H-2k) ABM or dm1 (Dd, Ld mutant) ABM. Flow cytometry analysis with propidium iodide staining revealed that these p-CTL were specifically deleted by incubation with H-2d ABM, but not with H-2k ABM. These data indicate that ABM veto cells kill p-CTL with specificity for antigens expressed on the surface of the ABM, and that the mechanism for veto cell activity of ABM is clonal deletion of p-CTL.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Mariotti, J., Foley, J., Ryan, K., Buxhoeveden, N., Kapoor, V., Amarnath, S., Fowler, D. H. (2008). Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway. Blood 112: 4765-4775 [Abstract] [Full Text]
Tyznik, A. J., Bevan, M. J. (2007). The Surprising Kinetics of the T Cell Response to Live Antigenic Cells. J. Immunol. 179: 4988-4995 [Abstract] [Full Text]
Gur, H., Krauthgamer, R., Bachar-Lustig, E., Katchman, H., Arbel-Goren, R., Berrebi, A., Klein, T., Nagler, A., Tabilio, A., Martelli, M. F., Reisner, Y. (2005). Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-{alpha}. Blood 105: 2585-2593 [Abstract] [Full Text]
Laughlin, M. J. (2005). Transplantation of 2 UCB units in adults. Blood 105: 915-916 [Full Text]
Tse, W., Laughlin, M. J. (2005). Umbilical Cord Blood Transplantation: A New Alternative Option. ASH Education Book 2005: 377-383 [Abstract] [Full Text]
Reich-Zeliger, S., Bachar-Lustig, E., Gan, J., Reisner, Y. (2004). Tolerance Induction by Veto CTLs in the TCR Transgenic 2C Mouse Model. I. Relative Reactivity of Different Veto Cells. J. Immunol. 173: 6654-6659 [Abstract] [Full Text]
Bachar-Lustig, E., Reich-Zeliger, S., Reisner, Y. (2003). Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. Blood 102: 1943-1950 [Abstract] [Full Text]
Gur, H., Krauthgamer, R., Berrebi, A., Klein, T., Nagler, A., Tabilio, A., Martelli, M. F., Reisner, Y. (2002). Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34+ cells. Blood 99: 4174-4181 [Abstract] [Full Text]
Umemura, A., Morita, H., Chang Li, X., Tahan, S., Monaco, A. P., Maki, T. (2001). Dissociation of Hemopoietic Chimerism and Allograft Tolerance After Allogeneic Bone Marrow Transplantation. J. Immunol. 167: 3043-3048 [Abstract] [Full Text]
Blazar, B. R., Lees, C. J., Martin, P. J., Noelle, R. J., Kwon, B., Murphy, W., Taylor, P. A. (2000). Host T Cells Resist Graft-Versus-Host Disease Mediated by Donor Leukocyte Infusions. J. Immunol. 165: 4901-4909 [Abstract] [Full Text]
Bachar-Lustig, E., Li, H. W., Gur, H., Krauthgamer, R., Marcus, H., Reisner, Y. (1999). Induction of Donor-Type Chimerism and Transplantation Tolerance Across Major Histocompatibility Barriers in Sublethally Irradiated Mice by Sca-1+Lin- Bone Marrow Progenitor Cells: Synergism With Non-Alloreactive (Host x Donor)F1 T Cells. Blood 94: 3212-3221 [Abstract] [Full Text]
Waller, E. K., Ship, A. M., Mittelstaedt, S., Murray, T. W., Carter, R., Kakhniashvili, I., Lonial, S., Holden, J. T., Boyer, M. W. (1999). Irradiated Donor Leukocytes Promote Engraftment of Allogeneic Bone Marrow in Major Histocompatibility Complex Mismatched Recipients Without Causing Graft-Versus-Host Disease. Blood 94: 3222-3233 [Abstract] [Full Text]
Hansal, S. A., Morris, D. I., Sechler, J. M. G., Love, P. E., Rosenberg, A. S. (1998). Cutting Edge: Induction of Antigen-Specific Hyporesponsiveness by Transplantation of Hemopoietic Cells Containing an MHC Class I Transgene Regulated by a Lymphocyte-Specific Promoter. J. Immunol. 161: 1063-1068 [Abstract] [Full Text]
Fowler, D. H., Whitfield, B., Livingston, M., Chrobak, P., Gress, R. E. (1998). Non-Host-Reactive Donor CD8+ T Cells of Tc2 Phenotype Potently Inhibit Marrow Graft Rejection. Blood 91: 4045-4050 [Abstract] [Full Text]
Zoller, M., Schmidt, A., Denzel, A., Moll, J. (1997). Constitutive Expression of a CD44 Variant Isoform on T Cells Facilitates Regaining of Immunocompetence in Allogeneic Bone Marrow Transplantation. Blood 90: 873-885 [Abstract] [Full Text]